Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4

[1]  L. Holle,et al.  Atypical presentation of fever as hypersensitivity reaction to oxaliplatin , 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[2]  Li Zhang,et al.  Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis , 2015, Journal of Cancer Research and Clinical Oncology.

[3]  I. Bekeredjian-Ding,et al.  Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia , 2015, Supportive Care in Cancer.

[4]  S. Johnston,et al.  Febrile neutropaenia and chemotherapy discontinuation in women aged 70 years or older receiving adjuvant chemotherapy for early breast cancer. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[5]  T. Nakajima,et al.  Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer , 2014, Cancer Immunology, Immunotherapy.

[6]  M. Paesmans,et al.  Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Armitage,et al.  Colony-stimulating factors for febrile neutropenia during cancer therapy. , 2013, The New England journal of medicine.

[8]  C. Flowers,et al.  Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  O. Lortholary,et al.  Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia. , 2008, The Lancet. Infectious diseases.

[10]  S. Steinberg,et al.  A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. , 1999, The New England journal of medicine.

[11]  P. Pizzo,et al.  Management of fever in patients with cancer and treatment-induced neutropenia. , 1993, The New England journal of medicine.

[12]  P. Mackowiak,et al.  Drug fever: a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature. , 1987, Annals of internal medicine.

[13]  P. A. Tabor.  Drug-Induced Fever , 1986, Drug intelligence & clinical pharmacy.

[14]  D. Norman,et al.  Fever and Aging , 1985 .

[15]  F. Kiernan,et al.  Effect of Aging on the Clinical Significance of Fever in Ambulatory Adult Patients , 1984, Journal of the American Geriatrics Society.

[16]  M. Kotler,et al.  Managing angina with calcium channel blockers. , 1982, Geriatrics.

[17]  Finkelstein Ms.  Unusual features of infections in the aging. , 1982 .

[18]  J. Callen,et al.  Fever as a complication of low dose irradiation. , 1977, The British journal of radiology.

[19]  M. V. Herik.  FEVER AS A COMPLICATION OF RADIATION THERAPY FOR CARCINOMA OF THE CERVIX , 1965 .

[20]  M. Finkelstein.  Unusual features of infections in the aging. , 1982, Geriatrics.